513.0000 -7.65 (-1.47%)
NSE Aug 05, 2026 13:25 PM
Volume: 61,169
 

513.00
-1.47%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters pledged 5.54% of shares in last quarter. Total pledge stands at 37.11% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended